SS
State Street Corp cut its BCRX stake below 5%
State Street Corp reported owning 4.8% of Biocryst Pharmaceuticals Inc (BCRX) (12,294,412 shares) in a Schedule 13G filed Nov 10, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 10, 2026
- Source
- Schedule 13G